DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE CLR222

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2019-12-10 for DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE CLR222 manufactured by Ethicon Inc..

Event Text Entries

[185480690] (b)(4). To date the device has not been returned. If the device or further details are received at a later date a supplemental medwatch will be sent. Attempts are being made to obtain the following information. To date no response has been provided. If further details are received at a later date a supplemental medwatch will be sent. How was the wound reaction managed? How was the reaction treated (prescription steroids; antibiotics prescribed)? Please describe how was the adhesive applied on the tape. What prep was used prior to, during or after prineo use? Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? Is the patient hypersensitive to pressure sensitive adhesives? Were any patch or sensitivity tests performed? What is the physicians opinion of the contributing factors to the reaction? What is the most current patient status? Is the product or representative sample (product from the same lot number) available for evaluation? Patient demographics: initials / id; age or date of birth; bmi ; gender. Patient pre-existing medical conditions (ie. Allergies, history of reactions). Was prineo/demabond or skin adhesive used on the patient in a previous surgery or wound closure?
Patient Sequence No: 1, Text Type: N, H10


[185480691] It was reported that the patient underwent total knee replacement on (b)(6) 2019 and topical skin adhesive was used. Post-operatively, the patient experienced a skin reaction at the surgical site aligned with the topical skin adhesive. The patient was re-admitted to manage wound reaction and superficial site infection risk. The patient experienced mild blisters and inflammation. The topical skin adhesive was removed and patient received wound reaction management. The surgeon opined they do not believe the patient experienced a true topical skin adhesive reaction and much of the redness was pink prep left under the topical skin adhesive. Following immediate removal of the topical skin adhesive, the patient progress was reported as very well. Additional information has been requested.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2019-90728
MDR Report Key9445556
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2019-12-10
Date of Report2019-11-18
Date of Event2019-11-18
Date Mfgr Received2020-01-17
Date Added to Maude2019-12-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKARA DITTY-BOVARD
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone6107428552
Manufacturer G1ETHICON INC.-SAN LORENZO PR
Manufacturer StreetROAD 183, KM. 8.3
Manufacturer CitySAN LORENZO 00754
Manufacturer Postal Code00754
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE
Generic NameSURGICAL SEALANT
Product CodeOMD
Date Received2019-12-10
Model NumberCLR222
Catalog NumberCLR222
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 08876 US 08876


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2019-12-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.